Amarin Corporation

View All

pharma news
Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval

Wave Life Sciences has recently announced the discontinuation of its drug suvodirsen, for the treatment of a rare Duchenne Muscular Dystrophy mutation.  Duchenne Muscular Dystrophy is a progressive worsening of the skeletal and heart muscles resulting in weakness. The disorder, is due to deficient prot...

Find More